In summary, single-cell and tumor microbiome analyses in an independent validation cohort reinforced our observations from the discovery cohort, confirming that the poor prognosis of Fn-positive CRC patients is linked to the impairment of IgA-mediated mucosal immunity. The gene discussed is CD79A; the disease is neoplasm.